Join the Skin and Structure Infection group to help and get support from people like you.
Skin and Structure Infection News
Related terms: Complicated Skin and Skin Structure Infection, cSSSI
Thinking About a Tattoo? FDA Warns These Inks Could Be Dangerous
FRIDAY, May 9, 2025 — The U.S. Food and Drug Administration (FDA) is warning consumers and tattoo artists that two tattoo inks have tested positive for harmful bacteria and could lead to serious i...
Study Finds Sharp Rise in Dangerous Strep Infections
TUESDAY, April 8, 2025 – Severe and possibly deadly strep infections are on the rise in the U.S., a study published Monday in Journal of the American Medical Association said. The rate of invasive...
Bedsores More Likely In Short-Staffed Hospitals Leaning On Nurse OT, Travel Nurses
FRIDAY, April 4, 2025 – Hospitals could be short-changing patients if they lean too heavily on nurse staffing agencies or overtime hours, a new study says. Patients are much more likely to develop...
Bed Sores Can Slow Neurological Recovery After Spinal Cord Injury
TUESDAY, Dec. 10, 2024 – Bed sores can be more than debilitating and painful. Now a new study shows they can also dramatically impact a person’s recovery from a spinal cord injury. “Our study found t...
Burden of Superficial Cutaneous Fungal Infection Quantified in U.S.
FRIDAY, Nov. 15, 2024 – The burden of superficial cutaneous fungal infections (SCFIs) among outpatient visits in the United States is high and increasing, according to a study published online Oct....
Doctors Report First U.S. Cases of Sexually Transmitted Ringworm Rash
THURSDAY, Oct. 31, 2024 – Doctors in New York City are describing the first known U.S. cases of sexually transmitted ringworm, which can cause a nasty rash that can take months to bring under...
FDA Approves Zevtera (ceftobiprole medocaril sodium) for Bacteremia, Skin and Skin Structure Infections, and Pneumonia
Allschwil, Switzerland, April 04, 2024 – Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe...
Dalvance (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients
NORTH CHICAGO, Ill., July 23, 2021 /PRNewswire/ – AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) approved Dalvance® (dalbavancin) for the treatment of acute ...
FDA Approves Kimyrsa (oritavancin) for the Treatment of Adult Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
MORRISTOWN, N.J., March 15, 2021 (GLOBE NEWSWIRE) — Melinta Therapeutics, LLC (Melinta), a commercial-stage company focused on the development and commercialization of novel antibiotics, today a...
FDA Approves Nuzyra (omadacycline) for Community-Acquired Bacterial Pneumonia and Acute Skin and Skin Structure Infections
BOSTON, Oct. 02, 2018 (GLOBE NEWSWIRE) – Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) today announced that the U.S. Food and Drug Administration (FDA) has approved Nuzyra (omadacycline) for the...
Melinta Therapeutics Announces FDA Approval of Baxdela (delafloxacin) for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
NEW HAVEN, Conn, June 19, 2017 – Melinta Therapeutics, a privately held company focused on discovering, developing, and commercializing novel antibiotics to treat serious bacterial infections, a...
Allergan Receives FDA Approval of Teflaro (ceftaroline fosamil) for Pediatric Patients
DUBLIN, May 31, 2016 /PRNewswire/ – Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has approved the company's...
Theravance Biopharma Announces FDA Approval of Expanded Label for Vibativ (telavancin)
DUBLIN, IRELAND – (Marketwired) – 05/09/16 – Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that the U.S. Food and Drug Administration (FDA)...
Allergan Announces FDA Approval of Updated Label for New Dosing Regimen for Dalvance (dalbavancin)
DUBLIN, Jan. 21, 2016 /PRNewswire/ – Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has approved the company's...
FDA Approves Orbactiv (oritavancin) to Treat Skin and Skin Structure Infections
August 6, 2014 – The U.S. Food and Drug Administration today approved Orbactiv (oritavancin), a new antibacterial drug to treat adults with skin infections. Orbactiv is approved to treat patients...
Further information
Related condition support groups
Related drug support groups
amoxicillin, doxycycline, metronidazole, cephalexin, clindamycin, azithromycin, Cipro, ciprofloxacin, Zithromax, view more... mupirocin, Augmentin, levofloxacin, erythromycin, Bactroban, clarithromycin, vancomycin, amoxicillin / clavulanate, cefdinir, sulfamethoxazole / trimethoprim, Rocephin